List of Cetylev drug patents
Cetylev is owned by Arbor Pharms Llc.
Cetylev contains Acetylcysteine.
Cetylev has a total of 3 drug patents out of which 0 drug patents have expired.
Cetylev was authorised for market use on 29 January, 2016.
Cetylev is available in tablet, effervescent;oral dosage forms.
Cetylev can be used as method of treating acetaminophen overdose with acetylcysteine solutions.
The generics of Cetylev are possible to be released after 08 May, 2032.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8747894 | ARBOR PHARMS LLC | Effervescent compositions containing N-acetylcysteine |
May, 2032
(8 years from now) | |
| US9561204 | ARBOR PHARMS LLC | Effervescent compositions containing N-acetylcysteine |
May, 2032
(8 years from now) | |
| US9427421 | ARBOR PHARMS LLC | Effervescent compositions containing N-acetylcysteine |
May, 2032
(8 years from now) | |
Drugs and Companies using ACETYLCYSTEINE ingredient
Market Authorisation Date: 29 January, 2016
Treatment: Method of treating acetaminophen overdose with acetylcysteine solutions
Dosage: TABLET, EFFERVESCENT;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic